Starpharma Holdings Limited Stock Today
| SPHRF Stock | USD 0.10 0.00 0.00% |
Performance0 of 100
| Odds Of DistressLess than 9
|
Starpharma Holdings is trading at 0.1 as of the 23rd of April 2024. This is a No Change since the beginning of the trading day. The stock's lowest day price was 0.1. Starpharma Holdings has less than a 9 % chance of experiencing financial distress in the next few years, but has generated negative returns over the last 90 days. Equity ratings for Starpharma Holdings Limited are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 24th of March 2024 and ending today, the 23rd of April 2024. Click here to learn more.
Starpharma Holdings Limited, a biopharmaceutical company, engages in the research, development, and commercialization of dendrimer products for pharmaceutical, life-science, and other applications worldwide. The company was founded in 1996 and is headquartered in Abbotsford, Australia. The company has 408.92 M outstanding shares. More on Starpharma Holdings Limited
Moving against Starpharma OTC Stock
| 0.8 | GLUC | Glucose Health Earnings Call This Week | PairCorr |
| 0.7 | SLF | Sun Life Financial Financial Report 9th of May 2024 | PairCorr |
| 0.67 | NONOF | Novo Nordisk AS | PairCorr |
| 0.64 | NVO | Novo Nordisk AS Financial Report 2nd of May 2024 | PairCorr |
| 0.49 | REGN | Regeneron Pharmaceuticals Financial Report 2nd of May 2024 | PairCorr |
| 0.48 | WMT | Walmart Financial Report 16th of May 2024 | PairCorr |
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
Starpharma OTC Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Starpharma Holdings' investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Starpharma Holdings or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| CEO, Executive Director | Jacinth Fairley |
| Business Concentration | Biotechnology, Healthcare (View all Sectors) |
Starpharma Holdings Limited [SPHRF] is traded as part of a regulated electronic over-the-counter service offered by the NASD. The company currently falls under 'Small-Cap' category with a current market capitalization of 161.85 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Starpharma Holdings's market, we take the total number of its shares issued and multiply it by Starpharma Holdings's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Starpharma Holdings classifies itself under Healthcare sector and is part of Biotechnology industry. The entity has 408.92 M outstanding shares.
Starpharma Holdings Limited has accumulated about 49.92 M in cash with (13.16 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.12, which can makes it an attractive takeover target, given it will continue generating positive cash flow.
Check Starpharma Holdings Probability Of Bankruptcy
Ownership AllocationStarpharma Holdings shows a total of 408.92 Million outstanding shares. 30% of Starpharma Holdings outstanding shares are owned by institutional holders. Institutional investors are typically referred to investors that purchase positions in a given stock to benefit from reduced commissions. Consequently, institutional investors are subject to different rules and regulations than regular investors. Please look out for any change in current institutional holding as this could mean something significant has changed at the company or is about to change. Please note that no matter how many assets the company owns, if the real value of the company is less than the current market value, you may not be able to make money on it.
Check Starpharma Ownership Details
Starpharma Stock Price Odds Analysis
In reference to a normal probability distribution, the odds of Starpharma Holdings jumping above the current price in 90 days from now is about 20.0%. The Starpharma Holdings Limited probability density function shows the probability of Starpharma Holdings otc stock to fall within a particular range of prices over 90 days. Assuming the 90 days horizon Starpharma Holdings Limited has a beta of -0.1061. This usually implies as returns on the benchmark increase, returns on holding Starpharma Holdings are expected to decrease at a much lower rate. During a bear market, however, Starpharma Holdings Limited is likely to outperform the market. Additionally, starpharma Holdings Limited has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the NYSE Composite.
Based on a normal probability distribution, the odds of Starpharma Holdings to move above the current price in 90 days from now is about 20.0 (This Starpharma Holdings Limited probability density function shows the probability of Starpharma OTC Stock to fall within a particular range of prices over 90 days) .
Starpharma Holdings Risk Profiles
Investors will always prefer to have the highest possible return on investment while minimizing volatility. Starpharma Holdings market risk premium is the additional return an investor will receive from holding Starpharma Holdings long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Starpharma Holdings. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Although Starpharma Holdings' alpha and beta are two of the key measurements used to evaluate Starpharma Holdings' performance over the market, the standard measures of volatility play an important role as well.
| Mean Deviation | 0.5477 | |||
| Standard Deviation | 2.64 | |||
| Variance | 6.97 | |||
| Risk Adjusted Performance | (0.02) |
Starpharma Stock Against Markets
Picking the right benchmark for Starpharma Holdings otc stock is fundamental to making educated investment choices. Many naive investors compare their positions with the S&P 500 or with the Nasdaq. But these benchmarks are not all-inclusive and generally should be used only for large-capitalization equities or stock offerings from large companies. When the price of a selected benchmark declines in a down market, there may be an uptick in Starpharma Holdings otc stock price where buyers come in believing the asset is cheap. The opposite is true when the market is bullish; so, accurately picking the benchmark for Starpharma Holdings is critical whether you are bullish or bearish towards Starpharma Holdings Limited at a given time. Please also check how Starpharma Holdings' historical prices are related to one of the top price index indicators.
Be your own money manager
Our tools can tell you how much better you can do entering a position in Starpharma Holdings without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Idea Analyzer Now
Idea AnalyzerAnalyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas |
| All Next | Launch Module |
Starpharma Holdings Corporate Executives
Elected by the shareholders, the Starpharma Holdings' board of directors comprises two types of representatives: Starpharma Holdings inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Starpharma. The board's role is to monitor Starpharma Holdings' management team and ensure that shareholders' interests are well served. Starpharma Holdings' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Starpharma Holdings' outside directors are responsible for providing unbiased perspectives on the board's policies.
| Nigel Baade | CFO, Company Secretary | Profile |
How to buy Starpharma OTC Stock?
Before investing in Starpharma Holdings, you must ensure you fully understand your financial goals and how diversified (or not) your overall investments are now. Then, after you clearly understand your investment objectives, consider investing in Starpharma Holdings. To buy Starpharma Holdings stock, you can follow these steps:- Choose a brokerage firm: You need to select a brokerage firm to buy shares of Starpharma Holdings. Some popular options include Charles Schwab, Fidelity, TD Ameritrade, and Robinhood.
- Open an account: Once you have chosen a brokerage firm, you will need to open an account. You will be required to provide personal information, such as your name, address, and Social Security number.
- Fund your account: You will need to deposit funds into your brokerage account to purchase Starpharma Holdings stock. You can do this by transferring funds from your bank account or other investment accounts.
- Place your order: Once you have located Starpharma Holdings Limited stock in your brokerage account, you can place your order to buy it. You will need to specify the number of shares you want to buy and the price you are willing to pay.
- Monitor your investment: After you have purchased Starpharma Holdings Limited stock, you should monitor your investment to track its performance and make informed decisions about buying, selling, or holding the stock
It's important to note that investing in stocks, such as Starpharma Holdings Limited, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember various factors, including economic indicators, change in net worth, political events, company-specific news, and investor sentiment, can influence the stock market. These factors can cause fluctuations in stock prices and lead to market volatility affecting your buy or sell decision. However, volatility can also present opportunities for investors to make gains by buying stocks when prices are low and selling when they are high. It's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments.
Already Invested in Starpharma Holdings Limited?
The danger of trading Starpharma Holdings Limited is mainly related to its market volatility and OTC Stock specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of Starpharma Holdings is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than Starpharma Holdings. The Sharpe ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile Starpharma Holdings is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Starpharma Holdings Limited. Also, note that the market value of any otc stock could be tightly coupled with the direction of predictive economic indicators such as signals in metropolitan statistical area. You can also try the Piotroski F Score module to get Piotroski F Score based on the binary analysis strategy of nine different fundamentals.
Complementary Tools for Starpharma OTC Stock analysis
When running Starpharma Holdings' price analysis, check to measure Starpharma Holdings' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Starpharma Holdings is operating at the current time. Most of Starpharma Holdings' value examination focuses on studying past and present price action to predict the probability of Starpharma Holdings' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Starpharma Holdings' price. Additionally, you may evaluate how the addition of Starpharma Holdings to your portfolios can decrease your overall portfolio volatility.
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals |